Cerebral small vessel disease and Alzheimer’s disease

Zhiyou Cai, Chuanling Wang, Wenbo He, Hanjun Tu, Zhengang Tang, Ming Xiao, Liang Jun Yan

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

Cerebral small vessel disease (CSVD) is a group of pathological processes with multifarious etiology and pathogenesis that are involved into the small arteries, arterioles, venules, and capillaries of the brain. CSVD mainly contains lacunar infarct or lacunar stroke, leukoaraiosis, Binswanger’s disease, and cerebral microbleeds. CSVD is an important cerebral microvascular pathogenesis as it is the cause of 20% of strokes worldwide and the most common cause of cognitive impairment and dementia, including vascular dementia and Alzheimer’s disease (AD). It has been well identified that CSVD contributes to the occurrence of AD. It seems that the treatment and prevention for cerebrovascular diseases with statins have such a role in the same function for AD. So far, there is no strong evidence-based medicine to support the idea, although increasing basic studies supported the fact that the treatment and prevention for cerebrovascular diseases will benefit AD. Furthermore, there is still lack of evidence in clinical application involved in specific drugs to benefit both AD and CSVD.

Original languageEnglish
Article numberA196
Pages (from-to)1695-1704
Number of pages10
JournalClinical interventions in aging
Volume10
DOIs
StatePublished - 1 Jan 2015

Fingerprint

Cerebral Small Vessel Diseases
Alzheimer Disease
Lacunar Stroke
Cerebrovascular Disorders
Vascular Dementia
Leukoaraiosis
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Group Processes
Venules
Evidence-Based Medicine
Arterioles
Pathologic Processes
Vascular Diseases
Dementia
Arteries
Stroke
Brain
Pharmaceutical Preparations

Keywords

  • Cerebral microbleeds
  • Cerebrovascular diseases
  • Dementia
  • Lacunar infarct
  • Leukoaraiosis

Cite this

Cai, Zhiyou ; Wang, Chuanling ; He, Wenbo ; Tu, Hanjun ; Tang, Zhengang ; Xiao, Ming ; Yan, Liang Jun. / Cerebral small vessel disease and Alzheimer’s disease. In: Clinical interventions in aging. 2015 ; Vol. 10. pp. 1695-1704.
@article{d9d327ab15d14447a133998798ea9e64,
title = "Cerebral small vessel disease and Alzheimer’s disease",
abstract = "Cerebral small vessel disease (CSVD) is a group of pathological processes with multifarious etiology and pathogenesis that are involved into the small arteries, arterioles, venules, and capillaries of the brain. CSVD mainly contains lacunar infarct or lacunar stroke, leukoaraiosis, Binswanger’s disease, and cerebral microbleeds. CSVD is an important cerebral microvascular pathogenesis as it is the cause of 20{\%} of strokes worldwide and the most common cause of cognitive impairment and dementia, including vascular dementia and Alzheimer’s disease (AD). It has been well identified that CSVD contributes to the occurrence of AD. It seems that the treatment and prevention for cerebrovascular diseases with statins have such a role in the same function for AD. So far, there is no strong evidence-based medicine to support the idea, although increasing basic studies supported the fact that the treatment and prevention for cerebrovascular diseases will benefit AD. Furthermore, there is still lack of evidence in clinical application involved in specific drugs to benefit both AD and CSVD.",
keywords = "Cerebral microbleeds, Cerebrovascular diseases, Dementia, Lacunar infarct, Leukoaraiosis",
author = "Zhiyou Cai and Chuanling Wang and Wenbo He and Hanjun Tu and Zhengang Tang and Ming Xiao and Yan, {Liang Jun}",
year = "2015",
month = "1",
day = "1",
doi = "10.2147/CIA.S90871",
language = "English",
volume = "10",
pages = "1695--1704",
journal = "Clinical Interventions in Aging",
issn = "1176-9092",
publisher = "Dove Medical Press Ltd.",

}

Cai, Z, Wang, C, He, W, Tu, H, Tang, Z, Xiao, M & Yan, LJ 2015, 'Cerebral small vessel disease and Alzheimer’s disease', Clinical interventions in aging, vol. 10, A196, pp. 1695-1704. https://doi.org/10.2147/CIA.S90871

Cerebral small vessel disease and Alzheimer’s disease. / Cai, Zhiyou; Wang, Chuanling; He, Wenbo; Tu, Hanjun; Tang, Zhengang; Xiao, Ming; Yan, Liang Jun.

In: Clinical interventions in aging, Vol. 10, A196, 01.01.2015, p. 1695-1704.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Cerebral small vessel disease and Alzheimer’s disease

AU - Cai, Zhiyou

AU - Wang, Chuanling

AU - He, Wenbo

AU - Tu, Hanjun

AU - Tang, Zhengang

AU - Xiao, Ming

AU - Yan, Liang Jun

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Cerebral small vessel disease (CSVD) is a group of pathological processes with multifarious etiology and pathogenesis that are involved into the small arteries, arterioles, venules, and capillaries of the brain. CSVD mainly contains lacunar infarct or lacunar stroke, leukoaraiosis, Binswanger’s disease, and cerebral microbleeds. CSVD is an important cerebral microvascular pathogenesis as it is the cause of 20% of strokes worldwide and the most common cause of cognitive impairment and dementia, including vascular dementia and Alzheimer’s disease (AD). It has been well identified that CSVD contributes to the occurrence of AD. It seems that the treatment and prevention for cerebrovascular diseases with statins have such a role in the same function for AD. So far, there is no strong evidence-based medicine to support the idea, although increasing basic studies supported the fact that the treatment and prevention for cerebrovascular diseases will benefit AD. Furthermore, there is still lack of evidence in clinical application involved in specific drugs to benefit both AD and CSVD.

AB - Cerebral small vessel disease (CSVD) is a group of pathological processes with multifarious etiology and pathogenesis that are involved into the small arteries, arterioles, venules, and capillaries of the brain. CSVD mainly contains lacunar infarct or lacunar stroke, leukoaraiosis, Binswanger’s disease, and cerebral microbleeds. CSVD is an important cerebral microvascular pathogenesis as it is the cause of 20% of strokes worldwide and the most common cause of cognitive impairment and dementia, including vascular dementia and Alzheimer’s disease (AD). It has been well identified that CSVD contributes to the occurrence of AD. It seems that the treatment and prevention for cerebrovascular diseases with statins have such a role in the same function for AD. So far, there is no strong evidence-based medicine to support the idea, although increasing basic studies supported the fact that the treatment and prevention for cerebrovascular diseases will benefit AD. Furthermore, there is still lack of evidence in clinical application involved in specific drugs to benefit both AD and CSVD.

KW - Cerebral microbleeds

KW - Cerebrovascular diseases

KW - Dementia

KW - Lacunar infarct

KW - Leukoaraiosis

UR - http://www.scopus.com/inward/record.url?scp=84945900841&partnerID=8YFLogxK

U2 - 10.2147/CIA.S90871

DO - 10.2147/CIA.S90871

M3 - Review article

C2 - 26604717

AN - SCOPUS:84945900841

VL - 10

SP - 1695

EP - 1704

JO - Clinical Interventions in Aging

JF - Clinical Interventions in Aging

SN - 1176-9092

M1 - A196

ER -

Cai Z, Wang C, He W, Tu H, Tang Z, Xiao M et al. Cerebral small vessel disease and Alzheimer’s disease. Clinical interventions in aging. 2015 Jan 1;10:1695-1704. A196. https://doi.org/10.2147/CIA.S90871